Health system executives and boards of directors are likely to encounter four areas of concern as they recover from the pandemic’s impact and prepare for the future.
As hospitals faced the onslaught of scared patients fearing they had Covid-19, some organizations tip-toed into artificial intelligence to help serve as a first line of defense. The impact may send AI into the hospital mainstream.
Social distancing could become the new normal for months to come, until a vaccine develops. Here’s how some companies have adapted to these new rules.
While hospitals and other healthcare firms provide frontline protection against Covid-19, scammers and hackers have used the confusion to attack. And many healthcare boards have ignored cybersecurity, leaving organizations vulnerable.
In the fallout of COVID-19, technology has become the one sector that has uniquely benefited from the isolated workforce and the need for novel medicine. But the reliance on tech, medical technology and biotechnology in this uncertain time has provided opportunities for non-tech firms to unite with tech and medical leaders as well.
The COVID-19 crisis left organizations in a tough spot. How boards reacted in the face of this pressure may leave them liable, according to recent situations with similar outbreaks and illnesses.
In the U.S., where health insurance through an employer is the primary way to receive care, many patients may abstain from going to the doctor due to costs. This has the potential to further the spread of the virus and has put insurers in the spotlight.
The New York Times has reported that executives at Walgreens Boots Alliance asked consultants to remove findings from an internal report that included complaints from its employees. For a better way of making sure information isn’t hidden from the board, look towards this technology darling.
The healthcare industry has been a fountain of dealmaking lately. Companies wanting to make acquisitions or sell businesses this year should learn from the experts.
The efforts of President Donald Trump’s administration to force healthcare providers such as hospitals and drug makers to disclose pricing isn’t going down without a fight.